Mereo BioPharma is a clinical-stage biopharmaceutical company headquartered in London, specializing in developing therapies for oncology and rare diseases, including orphan drugs. The company focuses on advancing treatments for underserved patient populations in rare disease sectors. With a targeted clinical pipeline, Mereo BioPharma demonstrates expertise in rare disease therapeutics and oncology drug development.
Mereo BioPharma is a clinical-stage biopharmaceutical company headquartered in London, specializing in developing therapies for oncology and rare diseases, including orphan drugs. The company focuses on advancing treatments for underserved patient populations in rare disease sectors. With a targeted clinical pipeline, Mereo BioPharma demonstrates expertise in rare disease therapeutics and oncology drug development.